STRO
Sutro Biopharma, Inc.Company with tickers: STRO
CIK
1382101
CUSIP
869367201
Shares Outstanding
16,570,439
Website
https://www.sutrobio.com
Investor Relations
https://ir.sutrobio.com/
13F Activity (30d)
2 filings
2 filers
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding STRO
17 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Eventide Healthcare & Life Sciences Fund | — | 715,307 | $17,818,297 | 1.12% | Long | 2026-03-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 533,124 | $13,280,119 | 0.00% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 169,063 | $4,211,359 | 0.01% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 43,751 | $895,583 | 0.00% | Long | 2026-02-28 | |
| iShares Micro-Cap ETF | — | 20,757 | $517,057 | 0.04% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 13,417 | $274,646 | 0.00% | Long | 2026-02-28 | |
| VANGUARD BALANCED INDEX FUND | — | 9,336 | $232,560 | 0.00% | Long | 2026-03-31 | |
| Fidelity Series Total Market Index Fund | — | 11,118 | $227,585 | 0.00% | Long | 2026-02-28 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 8,811 | $219,482 | 0.00% | Long | 2026-03-31 | |
| Goldman Sachs Absolute Return Tracker Fund | — | 4,092 | $101,932 | 0.00% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 4,596 | $94,080 | 0.00% | Long | 2026-02-28 | |
| Ultra-Small Company Market Fund | — | 3,000 | $74,730 | 0.06% | Long | 2026-03-31 | |
| TIFF MULTI-ASSET FUND | — | 1,518 | $37,813 | 0.00% | Long | 2026-03-31 | |
| 1290 VT Micro Cap Portfolio | — | 1,480 | $36,867 | 0.02% | Long | 2026-03-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 770 | $19,181 | 0.00% | Long | 2026-03-31 | |
| Small Cap Core Fund | — | 252 | $6,277 | 0.00% | Long | 2026-03-31 | |
| ProShares Ultra Nasdaq Biotechnology | — | 1 | $20 | 0.00% | Long | 2026-02-28 |
Showing 1–17 of 17 positions